SCHEMBL2895052

SCHEMBL2895052

O=[PH](O[PH](=O)c1ccccc1)c1ccccc1

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.32
LMNA P02545 2/20 0.32
LTA4H P09960 1/20 0.32
TSHR P16473 1/20 0.32
F2 P00734 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3668208 0.78
SCHEMBL258394 0.78 CA4 (0.38) ALDH1A1LMNALTA4HTSHR
SCHEMBL12408572 0.78 TSHR (0.35) ALDH1A1LMNATSHRF2
SCHEMBL9979839 0.78 IDO1 (0.33) ALDH1A1TSHR
SCHEMBL20233123 0.76 SRC (0.30)
SCHEMBL258292 0.76 CA4 (0.36) ALDH1A1LMNALTA4HTSHR
SCHEMBL258694 0.76 LTA4H (0.39) LTA4HTSHR
SCHEMBL258618 0.76 CA4 (0.36) ALDH1A1LMNALTA4HTSHR
SCHEMBL258478 0.76 CA4 (0.36) ALDH1A1LMNALTA4HTSHR
SCHEMBL3666357 0.76 CA4 (0.36) ALDH1A1LMNALTA4HTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7681741-B2 Functional polyarylethers GENERAL ELECTRIC COMPANY (US) 2010-03-23 US claimed
US-7669720-B2 Functional polyarylethers GENERAL ELECTRIC COMPANY (US) 2010-03-02 US claimed
US-20080319155-A1 OPTOELECTRONIC POLYMER COMPOSITIONS, AND DEVICES THEREFROM GENERAL ELECTRIC COMPANY (US) 2008-12-25 US claimed
WO-2008156928-A1 OPTOELECTRONIC POLYMER COMPOSITIONS, AND DEVICES THEREFROM GENERAL ELECTRIC COMPANY (US) 2008-12-24 WO claimed
US-20080142418-A1 FUNCTIONAL POLYARYLETHERS GENERAL ELECTRIC COMPANY (US) 2008-06-19 US claimed
US-20080142429-A1 FUNCTIONAL POLYARYLETHERS GENERAL ELECTRIC COMPANY (US) 2008-06-19 US claimed
WO-2008073537-A1 FUNCTIONAL POLYARYLETERS GENERAL ELECTRIC COMPANY (US) 2008-06-19 WO claimed
WO-2008073536-A1 FUNCTIONAL POLYARYLETHERS GENERAL ELECTRIC COMPANY (US) 2008-06-19 WO claimed
CN-115335447-A Nucleating agent, resin composition, method for producing resin composition, and molded article 株式会社ADEKA 2022-11-11 CN disclosed
CN-111065674-B Composition, thermoplastic resin composition using the same, and molded article thereof 株式会社ADEKA 2022-02-22 CN disclosed
CN-111051412-B Composition, thermoplastic resin composition using the same, and molded article thereof 株式会社ADEKA 2022-02-08 CN disclosed
CN-110382559-B Method for producing stabilized olefin resin composition 株式会社ADEKA 2021-10-29 CN disclosed
CN-111065674-A Composition, thermoplastic resin composition using the same, and molded article thereof 株式会社ADEKA 2020-04-24 CN disclosed
CN-111051412-A Composition, thermoplastic resin composition using the same, and molded article thereof 株式会社ADEKA 2020-04-21 CN disclosed
US-20080142418-A1 FUNCTIONAL POLYARYLETHERS GENERAL ELECTRIC COMPANY (US) 2008-06-19 US disclosed
US-20080142418-A1 FUNCTIONAL POLYARYLETHERS GENERAL ELECTRIC COMPANY (US) 2008-06-19 US disclosed
US-20080142429-A1 FUNCTIONAL POLYARYLETHERS GENERAL ELECTRIC COMPANY (US) 2008-06-19 US disclosed
US-20080142429-A1 FUNCTIONAL POLYARYLETHERS GENERAL ELECTRIC COMPANY (US) 2008-06-19 US disclosed
WO-2008073537-A1 FUNCTIONAL POLYARYLETERS GENERAL ELECTRIC COMPANY (US) 2008-06-19 WO disclosed
WO-2008073536-A1 FUNCTIONAL POLYARYLETHERS GENERAL ELECTRIC COMPANY (US) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080142429-A1 FUNCTIONAL POLYARYLETHERS CBR3, NR2E3, HRH4 ALDH1A1 4614/4885LMNA 4298/4885LTA4H 1013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.